At 17.1% CAGR, Bacteriophages Therapy Market Share, Current Trends and Research Development Report to 2028| Armata Pharmaceuticals, Inc., iNtODEWORLD, Inc, Phage International, Inc., Fixed Phage, Locus Biosciences

The bacteriophages therapy market size is expected to reach over US$ XX million by 2028. The growing prevalence of drug resistant infections along with the increasing foodborne diseases worldwide are the key factors for bacteriophages therapy market growth. Alchemy Research and Analytics LLP provided this information in a recently published report, titled, “Bacteriophages Therapy Market Size, Share & COVID-19 Impact Analysis, By Targeted Bacteria (Escherichia Coli, Staphylococcus, Streptococcus, Pseudomonas, Salmonella, and Others), By Application (Diagnostic, Antimicrobial Drug Discovery, Veterinary Medicines, and Others), By Route of Administration (Oral, Topical, and Parenteral), By End-User (Hospitals & Clinics, Academic Research Organizations & Institutes, and Others), and By Region(Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa), and Regional forecast,2020-2028.” The bacteriophages therapy report further mentions that the market size stood at US$ XX million in 2019, and it is likely to exhibit a CAGR of 17.1% during the forecast period between 2020 to 2028.

Get Sample Copy of this report@ https://www.alchemymarketresearch.com/pharmaceutical/global-bacteriophages-therapy-market/#req

The Increased prevalence of foodborne diseases

The growing prevalence of foodborne diseases among children’s as well as adults along with the increased research & development activities are the key factors for the global bacteriophages therapy market growth. As per recent data published in 2020, by the World Health Organization (WHO), over 40% children under the age of 5 carry foodborne diseases and 125,000 deaths due to foodborne diseases every year. Furthermore, in 2019, approximately 6.0 billion people (around 1 in 10 person globally) fall ill due to contaminated food and more than 420,000 deaths every year to foodborne diseases.

Get Methodology @ https://www.alchemymarketresearch.com/pharmaceutical/global-bacteriophages-therapy-market/#req

Rising merger & acquisitions among key market players

The increased mergers & acquisitions among major market players along with the rising demand for bacteriophages therapy in the developing economies such as India, China, and others due to high population are further anticipated to enhance the global bacteriophages therapy market growth during the forecast period. For instance, in January 2019, Janssen Pharmaceuticals Inc. (part of Johnson and Johnson Group) and Locus Biosciences Inc. collaborated to manufacture, develop, along with the commercialization of CRISPR-Cas3-enhanced bacteriophage (crPhage) products which are targeting two major bacterial pathogens for the treatment of respiratory tract infections as well as other related infections.

Alchemy Research and Analytics LLP, had taken the impact of the ongoing COVID-19 pandemic on the global bacteriophages therapy market for the year 2020 and 2021. As per our extensive secondary and primary research, the demand for bacteriophages therapy has increased in the COVID-19 period owing to high demand for respiratory tract infections treatment worldwide along with the permission from FDA for the phage therapy to COVID-19 patients.

Browse More Details at: https://www.alchemymarketresearch.com/pharmaceutical/global-bacteriophages-therapy-market

Key Manufacturers Aim to Enhance Their Portfolios by Partnerships

According to Alchemy Research and Analytics major market players in the bacteriophages therapy market are focusing on strategies such as partnerships, collaboration, acquisitions, and mergers to enhance their geographic presence as well as product portfolio. The bacteriophages therapy market is highly fragmented.

Alchemy Market Research lists out the names of key market players in the bacteriophages therapy market. They are as follows:



Armata Pharmaceuticals, Inc.,
iNtODEWORLD, Inc,
Phage International, Inc,
Fixed-Phage Limited,
LOCUS BIOSCIENCES, INC.,
Pherecydes Pharma,
Adaptive Phage Therapeutics, Inc.,
Intralytix, Phagelux, Inc.,
PhagoMed Biopharma GmbH,
ContraFect Corporation,
MICREOS,
Fixed-Phage Limited,
Phi Therapeutics.
BiomX,
Eligo Bioscience,
TechnoPhage,
Nextbiotics
Eliava Bio Preparations LTD
A Significant Industry Development-

February 2021: TechnoPhage, a clinical-stage biopharmaceutical company announced the beginning of Phase I/IIa study (REVERSE) of TP-102, a phage therapy candidate for the treatment of Diabetic Foot Infections (DFI). Furthermore, as per the company it is the first-in-human study which is designed to evaluate the safety and tolerability of TP-102 in subjects with both non-infected and infected Diabetic Foot Ulcers (DFU) as the primary endpoint with detection of significant reduction or eradication of target bacteria as secondary endpoints.
Further Report Findings-

Asia Pacific is estimated to witness the fastest growth in the global bacteriophages therapy market in the years to come due to the growing patient population and the rapid expansion of healthcare industry in the region.

North America accounted for the largest share in the global bacteriophages therapy market in 2019 due to the rising prevalence of foodborne diseases along with other infectious diseases.
Based on application, the global bacteriophages therapy market is further bifurcated into diagnostic, antimicrobial drug discovery, veterinary medicines, and others. In 2019, the diagnostic category had a substantial share in the global bacteriophages therapy market and estimated to witness substantial growth during the forecast period.

Contact Us
502, Tapaswi Aaradhna, Plot No. 11, Sector 34 B, Kharghar, Navi Mumbai – 410210
Email : sales@alchemymarketresearch.com
Website : https://www.alchemymarketresearch.com/

About Us
Alchemy Market Research is an innovative market intelligence company, helping customers to enrich their business scenario and make superior decisions using future intelligence tools. With lucid information database, we accomplish client’s expectation with high standard of commitments and addressing possible competitors in the market with complete SWOT analysis and exclusive market research reports.

Our research report involve both qualitative and quantitative analysis of current market scenario as per the market segment, product bifurcation, geographical regional segregations and exhaustive performance in diverse regions with global reach. Our syndicated research reports offers an exclusive analysis for the companies in alignment with the imminent modification in their domains.

This release was published on openPR.